🔎 Trials Near Me

Akèy › BPCO › Colorado

Etid klinik pou BPCO nan Colorado

15 etid pou BPCO ap chèche patisipan nan sit nan Colorado.

Vil nan Colorado

Tèks ofisyèl etid la (Anglè)

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  • Lynn Institute of Denver, Aurora
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • National Jewish Health Medical Center, Denver
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07759245

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • UCHealth - Medical Center of the Rockies, Loveland
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005, Boulder
  • Critical Care Pulmonary & Sleep Associates- Site Number : 8400081, Lakewood
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07190222

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • National Jewish Health, Denver
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Aurora
  • Research Site, Denver
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Lakewood
Ap rekriteFaz 3
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339

MoblO2 to Maintain Oxygenation

  • National Jewish Health, Denver
Ap rekrite
Laj 25 a 95 · Tout sèks · Mizajou Jul 22, 2026 · NCT07704567

SPIROMICS Study of Early COPD Progression (SOURCE)

  • National Jewish Health, Denver
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Ap rekriteFaz 2
Laj 35 a 89 · Tout sèks · Mizajou May 15, 2026 · NCT05937854

Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

  • University of Colorado Anschutz Medical Campus, Aurora
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT05896579

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

  • University of Colorado Anschutz Medical Campus, Aurora
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT07576894

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Aurora
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214

PiMZ Longitudinal Cohort (PiMZ Logic)

  • National Jewish Health, Denver
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06505603

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

  • University of Colorado, Denver
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 12, 2023 · NCT05306743

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.